Sunday, February 23, 2025

EMSAR Introduces Dave Elario as New Chief Executive Officer

Related stories

Copado Debuts AI DevOps Apps on Slack Marketplace

Copado, the leader in DevOps for business applications, introduced...

Together AI Raises $305M to Scale AI Acceleration Cloud

Together AI, the leading AI Acceleration Cloud, announced a...

Arize AI Raises $70M Series C to Make AI Work in Reality

Arize AI, a leading provider of AI observability and...

NTT DATA Launches Smart AI Agent™ to Boost AI Adoption

Next-generation AI tool will enhance operational efficiency, address global...
spot_imgspot_img

EMSAR planned for a seamless leadership transition to position their next phase of growth and Dave Elario comes to EMSAR with a rich history of key service leadership in high-profile global organizations.

EMSAR, a leading biomedical services company, is pleased to announce the appointment of Dave Elario as its new Chief Executive Officer (CEO), effective October 1st, 2023.

EMSAR planned for a seamless leadership transition to position their next phase of growth and Dave Elario comes to EMSAR with a rich history of key service leadership in high-profile global organizations. He played a critical role in managing GE Healthcare’s service business and held the reins of Johnson Controls’ North American service business. Throughout his career, Dave has demonstrated adept talent in steering service-oriented sectors toward successful outcomes.

“I am both excited and honored to join the dedicated team at EMSAR, a company already notable for its advanced capabilities and deep-rooted customer relationships,” said Elario.
“I am looking forward to leveraging the robust foundation established by Luc and the entire team, with an aim to not only continue, but amplify our journey toward establishing EMSAR as the undisputed leader in biomedical service.”

Also Read: Masimo Receives EU MDR CE Mark for LiDCO® Module for Hemodynamic Monitoring

In alignment with these changes, Jonielle Dedman has been promoted to Chief Operating Officer and Mark Hermes to Chief Commercial Officer. Both Jonielle and Mark have 15+ years of demonstrated success in leadership roles. They are eager to further EMSAR’s growth.

“As EMSAR embarks on its next chapter, there is a strong foundation for continued distinction,” said Luc Vallieres, former CEO. “EMSAR has transformed into an industry frontrunner, serving an impressive clientele of over 5,000 and spearheading multiple strategic acquisitions. The foundation of this success has been, without a doubt, the unparalleled dedication of the EMSAR team.”

ESMAR will continue dedicated service to medical device manufacturers and healthcare provider organizations. EMSAR’s next chapter emphasizes service expansion and operational excellence. With this new leadership team dedicated to its staff and clients, EMSAR is embracing the opportunities and growth ahead.

SOURCE: PRWeb

Subscribe

- Never miss a story with notifications


    Latest stories

    spot_img